Rebamipide Ophthalmic Suspension in the Treatment of Dry Eye: A Multicenter, Phase 3, Randomized, Double-Masked, Placebo-Controlled, Parallel-Group, 52-Week Study

Grants and Contracts Details

StatusFinished
Effective start/end date7/9/046/30/06

Funding

  • Otsuka Maryland Research Institute Inc: $10,664.00